Mehmet GÜVEN, İlhan ONARAN, Turgut ULUTİN, Gülgün S. GÜVEN, Seniha HACIHANEFİOĞLU

The effect of glutathione S-transferase M1 genotype on benzo[alpha]pyrene-induced sister chromatid exchanges and chromosomal aberrations in peripheral blood lymphocytes

Sister chromatid exchange (SCE) and chromosomal aberration (CA) in peripheral lymphocytes have been widely used in assessing exposure to mutagens and carcinogens. One of the extensively studied genotoxins is benzo[alpha]pyrene (BaP). The aim of the present study was to examine the ability of (BaP) to induce different individual cytogenetic response measured by SCE and CA frequency. The possible influence of genetic polymorphism was also taken into account, by including donors representing positive or null glutathione S-transferase M1 (GSTM1) genotypes. SCEs and CAs were analyzed from 72-h whole-blood lymphocyte cultures of 16 GSTM1 positive and 15 GSTM1 null donors after treatment with 5 µM BaP, which do not decrease cell viability. We found no influence of the GSTM1 genotype on SCE or CA frequency. The rates of chromatid and chromosome-type gaps and breaks induced in vitro by BaP were similar in all the groups. In the GSTM1 null genotype, however, chromatid-type breaks were seen more frequently than chromosome-type breaks after a 48 h treatment with BaP. These findings suggest that SCEs and CAs induced in vitro by BaP are not influenced by the genotype GSTM1.

PDF

___

1. Gupta R, Earley C, Sharma S. Use of human peripheral blood lymphocytes to measure DNA binding capacity of chemical carcinogens. Proc Natl Acad Sci USA 85: 3513-3517, 1988.
2. Nadon L, Siemiatycki J, Dewar R et al. Cancer risk due to occupational exposure to polycyclic aromatic hydrocarbons. Am J Ind Med 28: 303-324, 1995.
3. Vineis P, Caporaso N. Tobacco and cancer: epidemiology and the laboratory. Environ Health Perspect 103: 156-160, 1995.
4. Pastorelli R, Guanci ,M, Cerri A et al. Impact of inherited polymorphisms in glutathione S-transferase Ml, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol Biom Prevent 7: 703-709, 1998.
5. Gelboin HV. Benzo[oc]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60: 1107-1166, 1980.
6. Okano P, Miller HN, Robinson RC et al. Comparison of benzo[a]pyrene and (-)trans-7,8-dihydroxy-7,8-dihydrobenzo[cc] pyrene metabolism in human blood monocytes and lymphocytes. Cancer Res 39: 3184-3193, 1979.
7. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995.
8. Board P, Coggan M, Johnston P et al. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharm Ther 48: 357-369, 1990.
9. Nielsen PS, De Pater N, Okkels H et al. Environmental air pollution and DNA adducts in Copenhagen bus drivers — effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis 17: 1021-1027, 1996.
10. Wiencke JK, Kelsey KT, Lamela RA et al. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 50: 1585-1590, 1990.
11. Harrison DJ, Cantlay AM, Rae F et al. Frequency of glutathione S-transferase Ml deletion in smokers with emphysema and lung cancer. Hum Exp Toxico 16: 356-360, 1997.
12. Zhong S, Willie AH, Barnes D et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824, 1993.
13. Miller SA, Dykes DD, Polesky MF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
14. Tucker JD, Auletta A, Cimino MC et al. Sister-chromatid exchange: second report of the Gene-Tox Program. Mutat Res 297: 101-180, 1993.
15. Moorehead PS, Nowell PC, Mellman WJ et al. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res 20: 613-616, 1960.
16. Sullivan PD. Free radicals of benzo(a)pyrene and derivatives. Environ Health Prospect 64: 283-295, 1985.
17. Seidegard J, Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 105: 791-799, 1977.
18. Seidegard J, Pero RW. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet 69: 66-68, 1985.
19. Onaran I, Güven G, Ozaydin A et al. The influence of GSTM1 null genotype on susceptibility to in vitro oxidative stress. Toxicology 157: 195-205,2001.
20. Salama SA, Sierra-Torres CH, Oh HY et al. Variant metabolizing gene alleles determine the genotoxicity of benzo[oc]pyrene. Environ Mol Mutagen 37: 17-26, 2001.
21. Xiong P, Bondy ML, Li D et al. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res 61: 8465-8469, 2001.
22. Pastorelli R, Cerri A, Mezzetti M et al. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int J Cancer 100:9-13,2002.
23. Binkova B, Lewtas J, Mîskova I. Biomarker studies in northern Bohemia. Environ Health Perspect 104: 591-597, 1996.
24. Carstensen U, Alexandrie AK, Hoegstedt B et al. B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu). Mutat Res 289: 187-195, 1993.
25. Kalina I, Brezani P, Gajdosova D. Cytogenetic monitoring in coke oven workers. Mutat Res 417: 9-17, 1998.
26. Ichiba M, Hagmar L, Rannug A. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTM1 in chimneysweeps. Carcinogenesis 15: 1347-1352, 1994.
27. Topinka J, Binkova B, Mrackova G. DNA adducts in human placenta as related to air pollution and to GSTM1 genotype. Mutat Res 390: 59-68, 1997.
28. Mooney LV, Bell DA, Santella RM et al. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis 18: 503-509, 1997.
29. Wei Q, Gu J, Cheng L et al. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 56: 3975-3979, 1996.
30. Natarajan AT. Mechanisms for induction of mutations and chromosome alterations. Environ Health Perspect 101: 225-229, 1993.
31. Tang MS, Pierce JR, Doisy RP et al. Differences and similarities in the repair of two benzo[alpha]pyrene diol epoxide isomers induced DNA adducts by uvrA, uvrB, and uvrC gene products. Biochemistry 31: 8429-8436, 1992.
32. Gurtoo HL, Vaught JB, Marinello AJ et al. High-pressure liquid chromatographic analysis of benzo(alpha)pyrene metabolism by human lymphocytes from donors of different aryl hydrocarbon hydroxylase inducibility and antipyrine half-lives. Cancer Res 40: 1305-1310, 1980.
33. Thompson CL, Zadock MC, Lambert JM et al. Relationships among benzo(a)pyrene metabolism, benzo(alpha)-diolepoxide: DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. Cancer Res 49: 6503-6511, 1989.